NCT01741701View on ClinicalTrials.gov

A Pilot Study of Oxaloacetate in Subjects With Treated PD

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Parkinson's Disease
Interventions
DRUG

Oxaloacetate (OAA)

DRUG

Placebo

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

Terra Biological LLC

INDUSTRY

lead

University of Kansas Medical Center

OTHER

NCT01741701 - A Pilot Study of Oxaloacetate in Subjects With Treated PD | Biotech Hunter | Biotech Hunter